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Abstract
This study investigates the impact of pharmacy policies on patient waiting time in
the Chemotherapy Day Unit of the Netherland Cancer Institute - Antoni van Leeuwen-
hoek hospital (NKI-AVL). The project evaluated whether a reduction in waiting time
resulting from medication orders being prepared in advance of patient appointments
was justified, given that medications prepared in advance risked being wasted if pa-
tients arrived too sick for treatment. Within this context, we derive explicit expres-
sions to approximate patient waiting times and wastage costs allowing management
to see the tradeoff between these two metrics for different policies. Using a case study
and a simulation model, the approximations are evaluated. The explicit expressions
allow the analysis to be easily repeated when medication costs change or when new
medications/protocols are introduced. In the same vein, other hospitals with different
patient case mixes can easily complete the analysis in their setting. Finally, the out-
come from this study resulted in a new policy at the cancer centre which is expected
to decrease the waiting time by half while only increasing pharmacy’s costs by 1-2%.
Keywords: Stochastic Modelling, Queueing Systems, Pharmacy, Chemotherapy
1 Introduction
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) is a com-
prehensive cancer center, which provides hospital care and research and is located in
Amsterdam, The Netherlands. The hospital has 150 inpatient beds and sees about 24,000
new patients every year, making it approximately the size of a mid-sized general hospital.
As with many Dutch hospitals, in order to improve quality of care and to increase their
capacity, there is a trend toward providing more care in ambulatory (or outpatient) set-
tings. To accommodate the increasing volumes, outpatient departments are being asked
to examine their current operations to find ways to improve their department’s efficiency.
To this end, NKI-AVL has completed a number of studies of their chemotherapy
day unit (CDU). The CDU is a 30 bed outpatient department where patients receive
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chemotherapy treatment. A course of treatment typically requires weekly or bi-weekly re-
curring appointments over a number of months. Improvements at this CDU have been re-
ported on before. In work by [6], process improvements allowed more patients to be treated
using the same number of beds without increasing the workload. Another study [11] inves-
tigated how pooling resources would impact access times. The CDU is also concerned over
long waiting time for patients after their arrival at the hospital. Initial analysis indicated
that a large percentage of this wait was due to patients waiting for their chemotherapy
medication order to be completed by the pharmacy. We describe this process by which
medication orders are placed and completed and use operational research models to eval-
uate how changes affect the cost for the pharmacy and the waiting time for the patients.
The relationship between the pharmacy and the CDU is described below.
Patients receiving chemotherapy do so over a number of months with weekly or bi-
weekly appointments. Each appointment is scheduled at least one week in advance. On
the day of their appointment a patient either reports directly to the CDU or to the labo-
ratory. Patients reporting to the laboratory require a blood test, which is used to assess
if they are healthy enough (i.e. fit) to receive their scheduled course of chemotherapy.
Patients that are fit receive the chemotherapy, those that are not, are rescheduled for a
later time. In this case study we found that approximately 80% of the patients require a
blood test and approximately 10% of them are found to be unfit to receive chemotherapy.
Patients reporting directly to the CDU will receive a quick health check before receiving
the chemotherapy. Approximately 5% of these patients are found to be unfit.
With a few exceptions, current practice states that chemotherapy medications are not
to be prepared until after the patient is deemed ‘fit’ to receive treatment and, is present
in the CDU. This practice of preparing the medication ‘on demand’ is motivated by the
high cost of many of the medications. The pharmacy does not wish to prepare a medicine
before they are sure the patient can receive it, as this ensures no medicines are wasted.
They argue that since chemotherapy medications can cost up to 1800 euros per treatment,
it is prudent to be sure they will be used before preparing them. Indeed, unused medicine
may contribute considerably into the operational waste of a hospital [1].
Management of the CDU on the other hand, is concerned that to prepare the medicines
‘on-demand’ adds an extra process step that leads to unnecessary waiting for the patients.
For example, CDU management would prefer if the medications were prepared ‘in advance’
of the appointment so that patients could receive their chemotherapy immediately after
they have been found fit to receive it. They argue that the percentage of patients found
to be unfit is sufficiently low to justify making medications in advance.
To determine which (if any) medication should be made in advance a number of addi-
tional factors should be considered. Different medications have different shelf lives which
can dictate how soon in advance of an appointment a medicine can be prepared. Different
medications have different costs; generic drugs are significantly cheaper than brand name
drugs and those which are new. Some medications are more ‘toxic’ which results in a
higher percentage of unfit patients. Finally some medications are used more frequently
than others which allows them to be given to a different patient, should the original pa-
tient be found to be unfit. Because of these many factors and the uncertainty involved in
this process, it is unclear to management which medicines should be made ‘in advance’
and which medicines should be made ‘on demand.’
The purpose of this paper is two fold. First as a case study at NKI-AVL, we wish to
define a policy stating which medicine should be made in advance. This policy should strike
a balance between the cost of wasted medicines and the ‘cost’ of waiting patients. The
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second purpose is to describe and evaluate an analytical model with explicit expressions
that allows this analysis to be easily repeated at other hospitals.
Using operational research models to improve outpatient clinics is not new, however the
majority of studies focus on patient scheduling [2]. Improvements related to operational
processes have seen less attention, and in particular, models considering process of two
interacting departments are uncommon [5,12]. Most closely related to the work presented
in this paper is by [8] where the authors use a system dynamics simulation to study cost
and waiting times for a wide range of chemotherapy patient and drug types. Whereas
our model is used to define a policy to guide daily decision making by pharmacists, their
model considers how different chemotherapy delivery protocols affect patient satisfaction
and costs.
This paper contributes to the growing literature of health care management science
through the derivation of explicit expressions for patient waiting times and medication
costs, within the described context. Although this context is a specific operational area,
the problem is solved conclusively. The explicit expressions have the distinct advantage
over simulation techniques in that changes in model parameters can easily be accounted
for without needing to repeat model “runs”. Furthermore specific software and trained
modellers are not needed to repeat the analysis when medication costs change or when new
medications/protocols are introduced. In the same vein, other hospitals with a different
patient case mix can easily complete the analysis in their setting without specific software
or simulation knowhow.
The paper is organized as follows: the queueing system and model are introduced in
Section 2, the waiting time analysis in Section 3, and the analysis of the cost of wasted
medication orders in Section 4. The use of the model for policy decisions at NKI-AVL is
discussed in Section 5 and a general discussion on the model’s applicability to other other
hospitals is discussed in Section 6.
2 Model
The process introduced in the previous section is analyzed by both simulation and analyt-
ics. In this paper we describe the analytical model (which is an approximation) in detail,
and use a discrete event simulation of the same system to compare numeric results.
2.1 Model Flow
The queueing system for medication orders in the pharmacy is described as follows: The
system consists of two queues leading to a server with c pharmacists. Orders O1t go to the
first queue and wait there until being prepared. These orders are started only after their
corresponding patient is deemed fit and must be finished by the end of the day. Orders
O2t go to the second queue and are not required to be completed this day. These are the
orders for patients that will arrive to the hospital on the next day. At the end of each
day orders that are still present in the second queue, join the first queue the next day.
These orders are called the ‘backlog’ and are denoted by Lt. Orders in the first queue
have (non-preemptive) priority over orders in the second queue, since their corresponding
patients are waiting. Simply put, O1t order are those that are completed when the patient
arrives to the hospital (and is deemed fit for treatment) and O2t orders are made in advance
of the patient’s arrival.
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The queueing system for patients in the CDU is described as follows: Upon arrival it is
determined if patients are fit to receive their scheduled treatment of chemotherapy. Unfit
patients are sent home without receiving treatment. Fit patients whose medicine orders
are part of the ‘completed orders’ immediately receive the treatment. Fit patients whose
medicine orders are not part of the ‘completed orders’ must wait until their medication
order is complete before receiving treatment. Figure 1 depicts the flows of orders and
patients.
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Figure 1: The process model
The decision required in this problem is to determine which medicines should be de-
noted as O1t orders and conversely, which should be denoted as O
2
t orders. This decision
is evaluated based on the resulting waiting time for patients (Queue 3 from Figure 1) and
the expected cost of wasted medicines (medicines prepared in advance for patients who
are later found to be unfit to receive their treatment).
In our discrete event simulation we model the system exactly as described above and
evaluate each decision as a “what if” scenario. Analytically the system cannot be described
straightforwardly as it contains two time scales. Orders arrive during the whole day and
their waiting times are measured in minutes. The backlog on the other hand, occurs only
at the end of the day creating arrivals to Queue 1 on the next day.
In order to analyze the waiting time in this model analytically we split it into two
submodels. The first submodel observes the process on a day-to-day level and allows
us to determine the expected amount of backlog on a day. This submodel is described
in Subsection 3.1. Using the expected amount of backlog, and given that the arrival
rate at the first queue is known, the waiting times of the patients can be determined,
as described in Subsection 3.2. An analytic expression to compute the expected cost of
wasted medicines is described in Section 4. Both Sections 3 and 4 conclude with numerical
results related to the NKI-AVL case study. The data for this case study is introduced in
the following subsection.
2.2 Model Data
The total number of patients that arrive on a day t is denoted by Nt, Nt ∼ Poisson(λ)
following from the data. In this case study λ = 69.9. A workday of the the pharmacy
consists of 555 minutes, starting at 08:15h and ending at 17:30h. The chemotherapy
appointments start in batches every fifteen minutes from 08:15h until 15:30h. Thus, the
arrival of chemotherapy drug orders are spread over the period T = 450 minutes. From
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the data we derived that the number of arrivals at a fifteen minute time slot τ has a
Poisson(qτ · λ) distribution, where qτ is an estimated fraction of patients that arrive at
this time slot. Patients require a blood test with probability 0.8. Patients are found to
be unfit for treatment with probability 0.1, in the case they had a blood test, and with
probability 0.05, otherwise. This results in the fraction r = 0.8 ∗ 0.1 + 0.2 ∗ 0.05 = 0.09 of
unfit patients. In our case study we found this fraction to be the same for each type of
medicine, although in general it does not need to be.
Let the set of all 52 medicines be denoted by S. The set of medicines that are not
allowed to be made in advance (i.e. are O1t orders) is denoted by S1. The set of medicines
that are allowed to be made in advance (i.e. are O2t orders) is denoted by S2. We assume
that each patient requires medicine i ∈ S with probability pi independently of other
patients. It follows that the number of patients that need medicine i is Poisson(λ · pi)
distributed. The probability pi is determined as follows
pi =
fi∑
j∈S fj
,
where fi is the number of times medicine i was used in a year and varies between 1 and
2941. These numbers follow from the data of the hospital. The price of a medicine i is
denoted by ci and is ranging from 1.00 to 1756.99 euros per order.
The preparation times of the medicines are independent and identically distributed
and are denoted by B, which is uniformly distributed between 5 and 20 minutes, as per
the prediction of the pharmacists. The pharmacy is staffed by c = 2 pharmacists.
Medicine orders arrive at the pharmacy 24 hours before the appointment time of that
patient. The total number of orders that arrive on day t at the pharmacy is denoted by
Ot. The arriving orders are divided according to a given policy in O
1
t and O
2
t . Where O
1
t
corresponds to medicines in set S1 and O
2
t corresponds to medicines in S2.
3 Patient Waiting Times
3.1 Backlog
In this subsection we describe a slotted queueing model to calculate the expected amount
of backlog. Let Lt be the amount of backlog on day t, this Lt depends on the number of
orders O1t and O
2
t , the amount of backlog on the previous day Lt−1 and the capacity of
the pharmacy Kt. The capacity of the pharmacy is the maximum number of orders that
can be made on a day. This slotted model does not take the arrival time of the patients
into account, only the orders, which arrive in a batch the day before the patient arrives.
It is clear that the sum of Lt−1, O
1
t and O
2
t equals the total number of orders that need
to be handled on day t, so the following equation arises
Lt = (Lt−1 +O
1
t +O
2
t −Kt)
+, (1)
where x+ = max{x, 0}. Note that since each order has one corresponding patient then
O1t +O
2
t−1 = Nt. (2)
Assume that on each day the fraction
∑
i∈S2
pi of orders is allowed to be made in advance.
Then O2t−1 and O
2
t are identically Poisson distributed with parameter λ ·
∑
i∈S2
pi. Fol-
lowing the model assumptions O2t is independent of O
1
t . Since the expected number of
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patients is the same each day, also the following holds
O1t +O
2
t = Ot
d
= Nt,
Furthermore we make the natural assumption that the Ot is independent of Kt, then
equation (1) can be written as
Lt = (Lt−1 +Ot −Kt)
+. (3)
Equation (3) is known as Lindley’s equation (see e.g. [3]). A way to approach a solution of
the Lindley equation is by directly solving the corresponding Markov chain. The states of
this Markov chain are defined by the number of backlog orders. The transition probabilities
of this Markov chain are given by
Pij =
⎧⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎩
∑
∞
k=i P (Ot ≤ k − i)P (Kt = k) if j = 0,∑
∞
k=i−j P (Ot = j − i+ k)P (Kt = k) if 0 < j ≤ i,
∑
∞
k=0 P (Ot = j − i+ k)P (Kt = k) if j > i.
Since Ot is Poisson distributed, we have
Pij =
⎧⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎩
∑
∞
k=i
∑k−i
j=0
e−λλj−i+k
(j−i+k)! P (Kt = k) if j = 0,
∑
∞
k=i−j
e−λλj−i+k
(j−i+k)! P (Kt = k) if 0 < j ≤ i,
∑
∞
k=0
e−λλj−i+k
(j−i+k)! P (Kt = k) if j > i.
We modelKt as a normally distributed random variable with mean µ = 87.92 and variance
σ2 = 10.66. This follows from the renewal theory result, which implies that the number
of independent identically distributed random variables (preparation times) that can be
fitted in a large time interval (working day of the pharmacy) is approximately normally
distributed with mean and variance defined by the first three moments of the preparation
times, see e.g. Ross [9, Chapter 3]. In this case P (Kt = k) is approximated by P (k−0.5 <
Kt ≤ k + 0.5). Now to solve the Markov chain, the chain is considered to be finite with
N states, where N is sufficiently large such that the probability to transit to states larger
than N is negligible. The expected number of backlog orders (E[L]) follows from the
steady state distributions.
3.2 Waiting times
Knowing the amount of backlog, the total number of orders in the priority queue (queue
1) can be determined and the waiting times can then be approximated. We explain the
approximation in the following three subsections. In the first subsection, the load on the
system resulting from the different order types is determined. In the second subsection,
we explain how the batch arrival process can be approximately modelled by indepen-
dent and identically distributed random variables. This adaptation of the arrival process
makes it possible to use existing waiting time approximations to solve our problem. The
approximation chosen for our purpose is explained and formulated in the third subsection.
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Let the expected waiting time of patients that receive a medicine from set S1 be denoted
by E[WS1 ]. This includes the waiting time until a pharmacist starts working on the order
and the preparation time of the medicine. This is the only waiting time of concern in our
problem as the patients corresponding to these medicine order are present and waiting in
the hospital.
3.2.1 System Load
The pharmacy workload results from from the two order types, Oit, i = 1, 2 (see Figure 1).
Let λi be the average number of new orders for each arriving in one day (this excludes
possible backlog from the day before). The orders of type O1t are made by the pharmacy
on day t, only if the patient is found fit for treatment which happens with probability 1−r.
As many O2t orders as possible, within the opening hours of pharmacy, are completed on
day t. Those orders which are not completed due to a shortage of time form the backlog
L and are added to λ1 on day t+1. Furthermore, all orders arrive during the time period
when appointments take place, i.e. time period T . Thus, let ρ denote the amount of work
offered to the system per minute, then we can write
ρ = ρ1 + ρ2,
where
ρ1 = E[B](λ1 +E[L])(1 − r)/T, ρ2 = E[B]λ2/T
and B is the preparation times of the medicines as introduced in Subsection 2.2.
3.2.2 Arrival Process
We suggest to evaluate E[WS1 ] using the approximating formulas for the GI/G/c priority
queue. Note however that the inter-arrival times in our model are not independent and
identically distributed (i.i.d.) because patients arrive in batches, and the size of a batch
depends on the corresponding appointment slot. To remedy this, we make two approxi-
mation steps. First, we assume that the fraction qτ of patients arriving at slot τ is the
same for each τ = 1, . . . , T/d, where d is the time interval between two appointment slots.
Then the number of orders arriving at each slot becomes Poisson(λslot), with
λslot = (λ1 + E[L])(1 − r)d/T.
Next, we apply a so-called Equivalent Random Method. The idea of this method is in
replacing a non-i.i.d. sequence of random variables by i.i.d. random variables with the
same mean and variance, see [13] for classical references and [7] for recent applications in
health care. Thus, we need to compute the mean and variance of inter-arrival times in our
system and substitute these numbers into the approximation for the GI/G/c queue.
Let A1, A2, . . . be inter-arrival times between two subsequent patients. Obviously,
E[A] = d/λslot. Next, observe that the inter-arrival time between two patients arriving at
the same slot is zero. Hence, the renewal theory argument gives that
P (A > 0) =
E[# non-empty batches in one slot]
E[# patients in one slot]
=
1− e−λslot
λslot
.
Further, note that if k − 1 one slots are empty then the inter-arrival time between two
non-empty slots becomes kd. Thus, we derive
E[A2] =
1− e−λslot
λslot
∞∑
k=1
(kd)2e−(k−1)λslot(1− e−λslot) =
d2
λslot
1 + e−λslot
1− e−λslot
.
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Define c2X = Var(X)/(E[X])
2 . Then the calculations above give
c2A =
E[A2]
(E[A])2
− 1 =
λslot(1 + e
−λslot)
1− e−λslot
− 1.
3.2.3 Waiting Time
Now we are ready to provide the approximation for the waiting time in different scenarios.
First we consider S1 = S, this means no medicines are made in advance. Thereafter S1 is
considered to be a subset of S such that S2 = S\S1 is non-empty, i.e. some medicines are
made in advance.
In case S1 = S we have a queueing system with c servers (pharmacists) and independent
identically distributed service times. The number of arrivals per day is λ = λ1, and
by definition in this case E[L] = 0. We evaluate the waiting time of the patients in
this queueing system using the approximation from [14] for the average waiting time
W (GI/G/c) in the GI/G/c queue:
E[WS1 ] ≈ E[W (GI/G/c)] + E[B]
≈
(
c2A + c
2
B
2
)
E[W (M/M/c)] + E[B]
= E[B]c−1 ·D/[1− c−1 · ρ] + E[B], if S1 = S, (4)
whereD denotes the probability of delay in aM/M/c queue. The expressions for E[W (M/M/c)]
and D can be found e.g. in Tijms [10], the latter formula being given by
D =
ρc
c!
((
1−
ρ
c
) c−1∑
n=0
ρn
n!
+
ρc
c!
)−1
.
In the case where S1 ⊂ S such that S2 = S\S1 = ∅, a priority rule is used. The medicines
that are prepared for patients on that same day have priority over the medicines that
are prepared for the next day. The non-preemptive priority system is used, because the
pharmacists cannot shelve the unfinished medicine and resume preparation later. For this
priority system we use the approach of Federgruen and Groenevelt [4], which gives the
next approximation formula for the waiting time in the priority queue:
E[WS1 ] ≈
(
c2A + c
2
B
2
)
D · c−1/[1− c−1 · ρ1] + E[B], if S\S1 = ∅. (5)
The numerical results in the next section prove that our analytical approximations
give a correct picture concerning the expected waiting times.
3.3 Numeric Results
Given that there are S medications, and that each could be made in advance, then there are
S! different policies to evaluate. However in the interest of having an easily implementable
policy, NKI-AVL decided that a simple criteria to identify “make in advance” medicines
(i.e. O2t orders) should be used. To this end, the price of the medicine is used as the
criteria to indicate which medicines should be made in advance. Specifically, if the price
of a medicine is less thanM euros, then the medicine is to be made in advance. This limits
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the number of policies to evaluate to at most S. When M = 0 no medicine orders are
made in advance, and when M = 1000 all medicine orders (which have shelf life greater
than 24 hours and are not extremely expensive) are made in advance. Should a hospital
chose a different criteria for defining their policy, the analysis of Subsection 3.2, of course
remains valid. In the interest of brevity, the numeric results in this paper are limited to
only 9 policies, but include both border policies.
Table 1 shows for a chosenM the resulting λ1, the amount of backlog and the expected
waiting times of patients. The waiting times computed analytically and with simulation
are displayed.
Table 1: Waiting times for different policies M
Amount made E[L] E[WS1 ] E[WS1 ]
in advance: M λ1 (simulation) (simulation) (analytical)
None 0 69.9 0.00 46.1 55.89
10 66.1 0.01 42.3 42.21
20 57.0 0.03 33.7 28.62
30 46.4 0.05 26.3 22.43
40 34.7 0.07 21.1 19.17
100 22.2 0.08 18.0 17.33
200 18.7 0.09 17.3 16.99
500 18.2 0.09 17.2 16.94
All∗ 1000 6.3 0.09 15.6 16.13
*All medicines which have shelf life greater than 24 hours and not extremely expensive
The expected volume of backlog increases as more medicines are made in advance.
This is in line with the observation that if none of the medicines are made in advance then
there are no medicines in the second queue and there will be no backlog. In all cases,
patients only have to wait if their medicine was not allowed to be made in advance or if
their order was backlogged at the end of the previous day.
It is also not surprising that the waiting times are smallest in the case when most
medicines are made in advance. In this case only those people requiring a drug with
a shelf life of less than 24 hours wait for their medicine to be prepared. The results
show clearly that making more medicines in advance results in lower waiting times. The
difference between the numerical and analytical results is due to the two approximations in
(4). The first approximation replaces the original batch arrival process with i.i.d. arrivals,
which may result in an error of a couple of minutes. Next, we refer to the comments on
formula (70) in [14] for the conditions, under which the approximation for E[W (GI/G/c)]
is sufficiently precise.
4 Cost of the wasted medicine
The downside of making medicines in advance is that every order that is made in advance
has a probability to be wasted, resulting in additional costs for the pharmacy. In this
section we formulate an expression to compute the expected cost per day E[C] of wasted
medicines for a given PolicyM . First, we assume that all premade orders are wasted when
the corresponding patient is found to be unfit for treatment. In Subsection 4.2 we assume
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that these orders can be stored and later given to a different patient.
The expected cost per day E[C] can be calculated in straightforward manner. Recall
that S2 denotes the set of medicines that are allowed to be made in advance and let ci be
the price of medicine i and ri the probability that a treatment with medicine i is wasted
due to a patient being found unfit for treatment. Then the following holds
E[Corder] =
∑
i∈S2
(ci · ri · pi) + g · ri (6)
where g is the non material cost to pharmacy to prepare an order (i.e. overhead costs
and staff wages). In the NKI case study g = 0 (without loss of generality) since there was
no intention to reduce the number of pharmacy staff and therefore g was considered an
irrelevant sunk cost.
Knowing the cost per order and the frequency of orders, the expected daily cost can
be computed as follows,
E[C] = E[Corder] · E[Nt] =
∑
i∈S2
ci · ri · pi · λ. (7)
4.1 Numeric Results
In Table 2 the expected costs compute by (7) and by simulation are shown for various
policies M .
Table 2: Expected daily cost of wasted medicines for different policies M
Amount made E[C] E[C]
in advance: M (simulation) (analytical)
None 0 0.0 0.0
10 1.9 1.9
20 11.3 11.3
30 35.4 35.4
40 71.2 71.1
100 124.9 124.9
200 167.6 167.5
500 185.4 185.7
All* 1000 897.1 900.0
*All medicines which have shelf life greater than 24 hours and not extremely expensive
It is clear that if everything is made in advance the costs are very high. These high
costs motivate the analysis of possible storage of medicines after a cancelled treatment for
“reuse” by another patient.
4.2 Reuse of medicines
Reuse of the medicines reduces the cost for pharmacy, since fewer medicines will be wasted.
However, given the complications (and possible risks) associated with managing an in-
ventory of “to-be-reused” medicines, it is likely that only expensive and frequently used
medicines will be stored for later use; others will be discarded. To investigate the impact
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of reusing medicines we use a policy F to indicate which medicines can be stored for later
use and which will be discarded. The policy is such that if the expected wasted cost of
the medicine is higher than F , then it can be reused. Let E[Ci] be the expected wasted
cost of medicine i defined as ,
E[Ci] = ci · ri · pi · λ (8)
For a given M and F , Table 3 shows the expected cost for the pharmacy computed by
(7) under the assumption that all medicines i, where E[Ci] > F , get reused and thus do not
contribute into the waste. This assumption is reasonable since the “reuse” medicines are
only wasted if they expire before a subsequent order for that medicine is made. This occurs
more often when the probability of a patient requiring medicine i (pi) is low. According
to (8), such medicine are not selected for “reuse.” Furthermore, simulated results found
this assumption reasonable but have been omitted from the text for brevity. Note that
“reused” medicines require approximately the same amount of preparation time by the
pharmacists (e.g. to check or adjust the dosage) and therefore the waiting time for patients
is independent of F .
Table 3: Expected daily cost of wasted medicines for different policies M and F
Amount made F
in advance: M 300 100 50 20 10 5 1
None 0 0 0 0 0 0 0 0
10 1.9 1.9 1.9 1.9 1.9 1.9 0.6
20 11.3 11.3 11.3 11.2 11.3 11.3 1.5
30 35.4 35.4 35.4 35.4 35.4 20.8 2.3
40 71.1 71.1 71.1 71.1 44.4 22.8 2.3
100 124.9 124.3 124.9 79.2 52.5 30.9 3.6
200 167.5 167.5 167.5 94.4 67.6 36.2 3.6
500 185.7 185.7 185.7 112.5 73.7 42.3 4.2
1000 371.1 252.4 188.0 114.9 76.1 44.6 4.2
All* 2000 705.2 290.2 225.9 127.8 76.1 44.6 4.2
*All medicines which have shelf life greater than 24 hours
The results in Table 3 confirm the statement that the reuse of medicine reduces the
costs of the pharmacy. The more medicines that are stored for reuse the lower the costs
are. Based on these results it would be convenient to chose to store every medicine for
reuse. The hospital however also needs to take other criteria into account, particularly
related to safety requirements and inventory space.
5 Policy Decisions
The numeric results in Tables 1 and 2 show how the decision to make medicines in ad-
vance influences both the waiting time for patients and the costs for pharmacy. By showing
this tradeoff for different values of M we have allowed the hospital to make an informed
decision. In September of 2009, after considering the results presented in this paper, man-
agement from the pharmacy and the CDU agreed that the shorter waiting times justified
making some medicines in advance. Furthermore they chose to reuse their most expensive
medicines. Based on this research the hospital is currently making approximately 80% of
11
all medicines in advance. In this section we discuss and highlight the improvements from
this policy change.
To compare different values of M independent of F , Figure 2 plots M as a function of
both waiting times and costs. The results from both the simulation and analytic approach
are shown. The policies of the hospital in 2008 and 2010 are also shown.
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Figure 2: Costs and waiting times for different policies M
Each point on Figure 2 represents a different policy M . In general, results from the
analytical model give a lower estimate of the waiting times. However the analytical results
are close to those obtained by simulation when making multiple medicines in advance. The
figure shows clearly that the new policy (Policy 2010) decreases the expected waiting time
from 45 minutes to 23 minutes at a cost of e105 per day. It is important to realise that
waiting patients occupy a place in the chemotherapy unit, which is an indirect capacity
loss. In our case study, a gain of 20 minutes per patient spares about 23 person·hours
of waiting at the CDU per day! This capacity can be used for handling more patients,
thus yielding obvious benefits for the hospital and/or ensuring a high service level such
that the patients receive their appointments without delay [11]. On the other hand, the
cost bared by the pharmacy is reasonable considering that the pharmacy prepares almost
e8,000 worth of medicines per day, meaning the new policy accounts for only a 1-2%
percent increase in its costs.
Figure 3 also plots M as a function of both waiting times and costs. The difference
however is that in Figure 3, we consider a policy F ≈ 20 such that the most medicines are
reused.
Figure 3 shows clearly the lower cost achieved by reusing some medicines. Specifically
in this case, a waiting time of 23 minutes can be achieved at a cost of e70 per day. This
is e35 cheaper than the case where no medicines are reused.
6 Discussion
Initially this system at NKI-AVL was analyzed with a simulation model. This approach
was chosen due to the multiple time scales (which typically makes analytic analysis diffi-
cult) and because hospital staff were more familiar with this approach. However when the
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Figure 3: Costs and waiting times for different policies M , with the reuse of expensive
medicines (F ≈ 20)
case study component of this work was completed and it became apparent that improve-
ments would be realized, we sought to formulate an analytical solution which would be
easily reproduced in other settings or when prices of medicines changed. As such, other
hospitals with similar practice as the NKI-AVL can use the same methods to determine
the waiting times of the patients and the cost to the pharmacy.
In case no medicines are made in advance, equation (4) gives an approximation of
the waiting times. If a hospital has a policy of making multiple medicines in advance,
equation (5) should be used. Equation (7) gives the cost to the pharmacy for each policy.
The plots in Figures 2 and 3 can easily be reproduced in other hospitals to illustrate the
costs and waiting times associated with various policies M and F (and likewise for the
current policy). This approach leaves the decision autonomy with the hospital managers,
allowing them to decide how the waiting times of the patients and the cost of the pharmacy
should be balanced, (i.e. which metric should be given more weight).
The interactive nature of the two departments in this study is a prime area for further
study. The two departments have different and sometimes competing objectives and mod-
els such as the one presented in this paper are needed to quantify the concerns of both.
As shown, significant improvements in patient waiting times can be gained at a low cost
for the hospital.
A topic for future research would be to examine possible implications of our research
for the appointment scheduling at the CDU. In this paper we considered the appointment
schedule as given. However one can imagine that changes in the appointment schedule
will affect the workload at the pharmacy. On the other side the pharmacy could develop a
medicine preparation policy based on the appointment times of the patients at the CDU,
for instance, making medicines in advance only for patients that are scheduled in the
morning.
In this paper policy M is defined such that once we indicate that a medicine is to be
made in advance, all orders for this medicine are made in advance. It is likely that further
improvements are possible if we relax this restriction and further specify this policy. For
example we could choose which orders to make in advance based on all outstanding orders
by taking the length of the queue into account. This more complicated situation would
13
better reflect the current state of the system, however it would likely require a model in
real time. How to incorporate a “real time” policy into current practice, and examining if
the gains justified the more complex policy, are additional areas for further research.
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